Effects of Minimally Invasive Surgery for Patients With OSA on Quality of Life.
Saved in:
| Title: | Effects of Minimally Invasive Surgery for Patients With OSA on Quality of Life. |
|---|---|
| Authors: | Lin, Hsin-Ching, Lee, Chee-Yee, Friedman, Michael, Wang, Pa-Chun, Salapatas, Anna M., Lin, Meng-Chih, Chen, Yung-Che |
| Source: | Annals of Otology, Rhinology & Laryngology. Feb2018, Vol. 127 Issue 2, p118-123. 6p. |
| Subjects: | Emotions, Minimally invasive procedures, Health status indicators, Health surveys, Pain, Probability theory, Quality of life, Questionnaires, Sleep apnea syndromes, Snoring, Statistics, Tongue, Data analysis, Visual analog scale, Treatment effectiveness, Pre-tests & post-tests, Retrospective studies, Ablation techniques, Descriptive statistics, Symptoms, Psychology |
| Abstract: | Objective: To retrospectively study the effects of minimally invasive single-stage multilevel surgery (MISS MLS) for treating patients with obstructive sleep apnea/hypopnea syndrome (OSA) on quality of life (QOL). Methods: All OSA patients with multilevel obstruction who failed or refused continuous positive airway pressure (CPAP) treatment and then underwent Pillar implants and temperature-controlled radiofrequency of the base of tongue (RFBOT) were enrolled. The subjective symptoms and QOL (SF-36 Taiwan Standard Version 1.0) parameters were collected preoperatively and a minimum of 3 months postoperatively. Postoperative morbidity and complications were also recorded. Results: Thirty-seven patients (30 men, 7 women; mean age = 46.8 years; mean BMI = 23.9 kg/m²) were enrolled. The mean Epworth Sleepiness Scale changed from 12 ± 4.3 to 10.6 ± 4.3 (P = .004, Wilcoxon signed-rank test). The mean snoring visual analog scale reduced from 9.5 ± 1.3 to 4.0 ± 2.0 (P < .0001). The mean score of SF-36 increased from 65.5 ± 19.6 to 75.2 ± 16.7 (P = .001). The SF-36 subscales showed statistically significant changes, especially in bodily pain, roleemotional, and general health. Conclusion: The study demonstrated that MISS MLS was effective on QOL in selected patients for treating OSA patients who are unresponsive to conservative OSA therapy. [ABSTRACT FROM AUTHOR] |
| Copyright of Annals of Otology, Rhinology & Laryngology is the property of Sage Publications Inc. and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Database: | Psychology and Behavioral Sciences Collection |
|
Full text is not displayed to guests.
Login for full access.
|
|
| Abstract: | Objective: To retrospectively study the effects of minimally invasive single-stage multilevel surgery (MISS MLS) for treating patients with obstructive sleep apnea/hypopnea syndrome (OSA) on quality of life (QOL). Methods: All OSA patients with multilevel obstruction who failed or refused continuous positive airway pressure (CPAP) treatment and then underwent Pillar implants and temperature-controlled radiofrequency of the base of tongue (RFBOT) were enrolled. The subjective symptoms and QOL (SF-36 Taiwan Standard Version 1.0) parameters were collected preoperatively and a minimum of 3 months postoperatively. Postoperative morbidity and complications were also recorded. Results: Thirty-seven patients (30 men, 7 women; mean age = 46.8 years; mean BMI = 23.9 kg/m²) were enrolled. The mean Epworth Sleepiness Scale changed from 12 ± 4.3 to 10.6 ± 4.3 (P = .004, Wilcoxon signed-rank test). The mean snoring visual analog scale reduced from 9.5 ± 1.3 to 4.0 ± 2.0 (P < .0001). The mean score of SF-36 increased from 65.5 ± 19.6 to 75.2 ± 16.7 (P = .001). The SF-36 subscales showed statistically significant changes, especially in bodily pain, roleemotional, and general health. Conclusion: The study demonstrated that MISS MLS was effective on QOL in selected patients for treating OSA patients who are unresponsive to conservative OSA therapy. [ABSTRACT FROM AUTHOR] |
|---|---|
| ISSN: | 00034894 |
| DOI: | 10.1177/0003489417750164 |
